Skip to content
Screener

DENTSPLY SIRONA XRAY Cash & Equivalents

Cash & Equivalents at other companies

Align Technology logo
Align TechnologyALGN
$1.1B+22.3%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$1.13B+1.4%
Solventum logo
SolventumSOLV
$403M-18.1%
IAR
Integra LifeSciencesIART
$214.42M-1.6%
3D Systems logo
3D SystemsDDD
$86.52M-36.5%
Henry Schein logo
Henry ScheinHSIC
$138M+8.7%

Other financials

Income statement

See full
Revenue$898.0M-4.1%
Gross profit$493.0M+0.6%
Operating income$82.0M+164%
Net income$37.0M+182%
EPS (diluted)$0.18+182%

Balance sheet

See full
Total debt$2.3B-7.3%
Total equity$1.4B-31.1%
Total assets$5.2B-14.3%

Cash flow

See full
Operating cash flow$99.0M+106%
CapEx$44.0M+37.5%
Free cash flow$55.0M+244%

Valuation

See full
Market cap$2.64B-3.2%
Enterprise value$4.71B-3.1%
P/S0.7×0.0×

Profitability

See full
Gross margin49.5%-2.2pp
Operating margin-8.5%-3.5pp
Net margin-15%-4.4pp
FCF margin3.9%+0.2pp

Returns & leverage

See full
Return on equity-33%-3.7pp
Debt / equity1.7×+0.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: DENTSPLY SIRONA’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000818479-26-000255
Line itemJune 30, 2026December 31, 2025
Assets
Current Assets:
Cash and cash equivalents$239$326
Accounts and notes receivable-trade, net620688
Inventories, net665642
Prepaid expenses and other current assets404367
Total Current Assets1,9282,023
Property, plant, and equipment, net845861

Item 1 – Financial Statements

FAQ

What is DENTSPLY SIRONA's cash & equivalents?
DENTSPLY SIRONA (XRAY) reported cash & equivalents of $239M in Q2 2026.
How has DENTSPLY SIRONA's cash & equivalents changed year-over-year?
DENTSPLY SIRONA's cash & equivalents decreased by 33.4% year-over-year, from $359M to $239M.
What is the long-term trend for DENTSPLY SIRONA's cash & equivalents?
Over 5 years (2020 to 2025), DENTSPLY SIRONA's cash & equivalents has grown at a -5.7% compound annual growth rate (CAGR), from $438M to $326M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about DENTSPLY SIRONA's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude